-

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Sapio Lab Informatics Platform (Release 24.12) further optimizes productivity across lab workflows

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the launch of Release 24.12, introducing new tools for chemistry, molecular biology, GMP workflows, and immunogenicity. These advancements streamline lab operations, enhance accuracy, and support the growing demands of scientific research.

Highlights include:

  • Immunogenicity module: automated workflows for streamlined validation and robust data analysis.
  • Improved GMP workflows: integrated monitoring and testing capabilities reduce system load and enhance precision.
  • Enhanced chemistry representation: stereoisomer management with advanced relative stereochemistry support and refined substructure search capabilities.
  • Expanded molecular biology features: new capabilities for batch cloning and sequence assembly, and the introduction of a protein sequencer viewer.

Kevin Cramer, founder, CEO, and CTO of Sapio Sciences, commented: “Sapio’s mission is to accelerate discovery by simplifying the complexities of science, and the new capabilities in Release 24.12 demonstrate our commitment to delivering advanced yet intuitive functionality that empowers scientists to work faster and with greater confidence across complex workflows.”

Kevin continued: “The Sapio Platform continues to evolve to meet the demands of scientists in rapidly advancing research fields. The latest update reflects Sapio’s continued dedication to empowering researchers with advanced solutions to streamline processes, enhance data precision, and accelerate scientific discovery.”

Introducing the Immunogenicity module

First announced in October 2024, the new Immunogenicity (IgX) module simplifies control mapping, supports multiple validation workflows, and automates data analysis within Sapio LIMS (Laboratory Information Management System) and ELN (Electronic Lab Notebook). By reducing manual effort and ensuring data integrity, these features enable researchers to handle complex immunogenicity workflows more effectively while maintaining accuracy and reliability.

Enhancements to GMP workflows

The latest updates to Sapio’s GMP (Good Manufacturing Practice) module focus on refining monitoring and testing workflows, providing greater flexibility and precision. GMP workflows have been integrated into the Integrated Data View (IDV) outside the ELN, reducing system load and improving material and instrument tracking capabilities.

Environmental monitoring routines have been enhanced to capture a broader range of data, including text, True/False metrics, and numeric values. These updates allow users to add notes and additional metadata to batch records in test configurations, receive samples, launch testing workflows, and process analytical data more efficiently, streamlining overall GMP processes.

Advances in chemistry informatics

The chemistry module in Sapio LIMS and ELN now includes upgraded capabilities for managing and analyzing chemical data. These updates include enhanced relative stereochemistry support, which simplifies the handling of stereoisomers in naming, identification, and registration processes. Stereo resolution capabilities have also been added to the compound and reagent registries, enabling users to refine their searches by specifying stereospecific queries or broadening them to include all variants.

Additionally, capabilities have been added to define any number of registries to handle, for example, research compounds, chemical reagents, and/or virtual design compounds.

Expanded Molecular Biology capability

Sapio continues to enhance its molecular biology toolkit with a range of new features aimed at simplifying sequence assembly, alignment, and analysis. Batch cloning and combinatorial assembly capabilities have been added, enabling researchers to track and compare sequence derivatives and lineages seamlessly.

The introduction of a protein sequencer viewer allows for the direct import of InterProScan data, NCBI Protein Accession Numbers, or UniProt IDs, providing researchers with greater flexibility in their analysis. Additionally, protein sequences can now be directly translated alongside DNA sequences, streamlining the editing and analysis of protein products.

About Sapio Sciences

At Sapio Sciences, our mission is to improve lives by accelerating discovery and diagnostics. Our cloud-based solutions—LIMS, ELN, and Scientific Data Management—are unified on a flexible, configurable, and AI-powered informatics platform, streamlining complex workflows, unifying scientific data, and enabling faster, smarter decisions across biopharma research and development, clinical diagnostics, and manufacturing.

Trusted by global leaders and innovators worldwide, we support a wide range of best-in-class applications, from NGS genomic sequencing and bioanalysis to bioprocessing, stability studies, histopathology, antibody discovery, and in vivo studies.

For more information, visit www.sapiosciences.com and follow us on LinkedIn.

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

Sapio Sciences


Release Versions

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

More News From Sapio Sciences

Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the promotion of Gordon McCall to Chief Operating Officer (COO). McCall has served as the company’s Chief Financial Officer (CFO) since 2022 and brings a proven track record of leadership, strategic execution, and operational acumen. As COO, McCall will oversee the implementation of Sapio’s day-to-day operations, including leading global customer delivery teams, managing customer relationshi...

Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced Sapio Release 25.4, introducing a new Biorepository Management solution, enhanced sample management capabilities, and platform-wide enhancements designed to streamline lab operations and support high-throughput research environments. New Biorepository Management Solution The new Sapio Biorepository solution gives labs centralized, flexible management of biospecimens across multiple sites. De...

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. With the BioNeMo platform, researchers can accelerate drug discovery by leveraging science-specific AI frameworks...
Back to Newsroom